Danaher Co. (NYSE:DHR) Shares Sold by Roanoke Asset Management Corp NY

Roanoke Asset Management Corp NY lessened its position in Danaher Co. (NYSE:DHRFree Report) by 3.4% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 16,979 shares of the conglomerate’s stock after selling 589 shares during the period. Roanoke Asset Management Corp NY’s holdings in Danaher were worth $3,897,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. AMF Tjanstepension AB purchased a new position in shares of Danaher during the 3rd quarter worth approximately $5,923,000. Howard Capital Management Group LLC grew its holdings in Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after acquiring an additional 48 shares during the period. Mutual Advisors LLC raised its position in Danaher by 6.4% in the third quarter. Mutual Advisors LLC now owns 6,478 shares of the conglomerate’s stock worth $1,801,000 after acquiring an additional 390 shares in the last quarter. SteelPeak Wealth LLC lifted its holdings in Danaher by 5.7% in the third quarter. SteelPeak Wealth LLC now owns 1,420 shares of the conglomerate’s stock valued at $395,000 after acquiring an additional 76 shares during the period. Finally, Oak Ridge Investments LLC boosted its position in shares of Danaher by 7.2% during the 3rd quarter. Oak Ridge Investments LLC now owns 24,235 shares of the conglomerate’s stock worth $6,738,000 after purchasing an additional 1,626 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

DHR has been the subject of several recent analyst reports. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research note on Thursday, January 30th. Citigroup reduced their price target on shares of Danaher from $285.00 to $265.00 and set a “buy” rating for the company in a research report on Thursday, January 30th. Raymond James restated a “market perform” rating on shares of Danaher in a report on Monday, February 3rd. Bank of America raised Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price objective for the company in a report on Friday, December 13th. Finally, Barclays lowered their target price on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday, January 30th. Seven investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Get Our Latest Analysis on DHR

Danaher Trading Up 1.0 %

Shares of Danaher stock opened at $207.73 on Friday. The firm has a market cap of $148.47 billion, a PE ratio of 39.34, a P/E/G ratio of 2.66 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a fifty-two week low of $196.80 and a fifty-two week high of $281.70. The business’s fifty day moving average is $224.58 and its two-hundred day moving average is $245.09.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period last year, the business posted $2.09 EPS. Analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s dividend payout ratio is 24.24%.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 11.10% of the stock is currently owned by insiders.

Danaher Company Profile

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Read More

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.